• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Fecal Microbiota Transplantation for Recurrent Clostridioides difficile infection: The COVID-19 Era.

作者信息

Khanna Sahil, Pardi Darrell

机构信息

C. difficile clinic and Microbial Replacement Therapy program, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.

出版信息

Am J Gastroenterol. 2020 Jul;115(7):971-974. doi: 10.14309/ajg.0000000000000689.

DOI:10.14309/ajg.0000000000000689
PMID:32618640
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7273935/
Abstract
摘要

相似文献

1
Fecal Microbiota Transplantation for Recurrent Clostridioides difficile infection: The COVID-19 Era.粪便微生物群移植治疗复发性艰难梭菌感染：新冠疫情时代
Am J Gastroenterol. 2020 Jul;115(7):971-974. doi: 10.14309/ajg.0000000000000689.
2
Faecal microbiota transplantation for infection: Four years' experience of the Netherlands Donor Feces Bank.粪便微生物群移植治疗 感染：荷兰供体粪便银行四年经验。
United European Gastroenterol J. 2020 Dec;8(10):1236-1247. doi: 10.1177/2050640620957765. Epub 2020 Sep 29.
3
Advances in therapeutics.治疗学进展
Expert Rev Anti Infect Ther. 2021 Sep;19(9):1067-1070. doi: 10.1080/14787210.2021.1874919. Epub 2021 Jan 17.
4
[Reconsidering the technical aspects and quality management background of faecal microbiota transplantation due to the novel coronavirus pandemic].[鉴于新型冠状病毒大流行重新审视粪便微生物群移植的技术方面和质量管理背景]
Orv Hetil. 2020 Nov 1;161(44):1858-1871. doi: 10.1556/650.2020.32023.
5
Fecal microbiota transplantation and donor screening for Clostridioides difficile infection during COVID-19 pandemic.2019年冠状病毒病大流行期间艰难梭菌感染的粪便微生物群移植及供体筛查
J Formos Med Assoc. 2021 Feb;120(2):791-793. doi: 10.1016/j.jfma.2020.07.028. Epub 2020 Jul 23.
6
infection: a comprehensive review for primary providers.感染：初级保健提供者的综合综述。
Rom J Intern Med. 2021 Aug 26;59(3):262-269. doi: 10.2478/rjim-2021-0010. Print 2021 Sep 1.
7
Faecal microbiota transplantation for eradication of co-infection with and extensively drug-resistant KPC-producing .粪便微生物群移植治疗 合并广泛耐药碳青霉烯酶 KPC 产 感染
Scand J Gastroenterol. 2020 May;55(5):626-630. doi: 10.1080/00365521.2020.1753806. Epub 2020 Apr 23.
8
Faecal banking at -20 °C facilitates faecal microbiota transplantation for recurrent infection in clinical practice.在-20°C下进行粪便储存有助于在临床实践中对复发性感染进行粪便微生物群移植。
Infect Dis (Lond). 2020 Sep;52(9):662-665. doi: 10.1080/23744235.2020.1774075. Epub 2020 Jun 9.
9
Recurrent Clostridioides difficile Infection Is Associated With Impaired T Helper Type 17 Immunity to C difficile Toxin B.复发性艰难梭菌感染与17型辅助性T细胞对艰难梭菌毒素B的免疫功能受损有关。
Gastroenterology. 2021 Mar;160(4):1410-1413.e4. doi: 10.1053/j.gastro.2020.11.043. Epub 2020 Nov 27.
10
Fecal Microbiota Transplantation: The Evolving Risk Landscape.粪便微生物群移植：不断演变的风险格局
Am J Gastroenterol. 2021 Apr;116(4):647-656. doi: 10.14309/ajg.0000000000001075.

引用本文的文献

1
Gut microbiota in post-acute COVID-19 syndrome: not the end of the story.新冠后急性综合征中的肠道微生物群：故事尚未结束。
Front Microbiol. 2024 Dec 24;15:1500890. doi: 10.3389/fmicb.2024.1500890. eCollection 2024.
2
Family Stool Donation Predicts Failure of Fecal Microbiota Transplant for Infection.家族粪便捐献预示着粪便微生物群移植治疗感染的失败。
Gastro Hep Adv. 2022 Feb 3;1(2):141-146. doi: 10.1016/j.gastha.2021.11.007. eCollection 2022.
3
Clostridioides Infection: Landscape and Microbiome Therapeutics.艰难梭菌感染：现状与微生物组疗法
Gastroenterol Hepatol (N Y). 2023 Jun;19(6):319-328.
4
Recurrent Clostridioides difficile Infection: Current Clinical Management and Microbiome-Based Therapies.复发性艰难梭菌感染：当前的临床管理及基于微生物群的治疗方法
BioDrugs. 2023 Nov;37(6):757-773. doi: 10.1007/s40259-023-00617-2. Epub 2023 Jul 26.
5
Gut microbiota in COVID-19: new insights from inside.肠道微生物组在 COVID-19 中的作用：来自内部的新见解。
Gut Microbes. 2023 Jan-Dec;15(1):2201157. doi: 10.1080/19490976.2023.2201157.
6
The role of the gut microbiome in colonization resistance and recurrent infection.肠道微生物群在定植抗性和反复感染中的作用。
Therap Adv Gastroenterol. 2022 Nov 18;15:17562848221134396. doi: 10.1177/17562848221134396. eCollection 2022.
7
Application and development of fecal microbiota transplantation in the treatment of gastrointestinal and metabolic diseases: A review.粪便微生物群移植在治疗胃肠和代谢疾病中的应用和发展：综述。
Saudi J Gastroenterol. 2023 Jan-Feb;29(1):3-11. doi: 10.4103/sjg.sjg_131_22.
8
Manufacturing Process of SER-109, a Purified Investigational Microbiome Therapeutic, Reduces Risk of Coronavirus Transmission From Donor Stool.SER-109（一种纯化的研究性微生物组疗法）的制造过程降低了冠状病毒从供体粪便传播的风险。
Open Forum Infect Dis. 2022 Sep 2;9(9):ofac448. doi: 10.1093/ofid/ofac448. eCollection 2022 Sep.
9
infection: curbing a difficult menace.感染：遏制一项棘手的威胁。
Therap Adv Gastroenterol. 2022 Apr 15;15:17562848221089906. doi: 10.1177/17562848221089906. eCollection 2022.
10
Fecal microbiota transplantation for recurrent , safety, and pitfalls.粪便微生物群移植治疗复发性疾病、安全性及陷阱
Therap Adv Gastroenterol. 2021 Dec 23;14:17562848211053105. doi: 10.1177/17562848211053105. eCollection 2021.

本文引用的文献

1
Prolonged presence of SARS-CoV-2 viral RNA in faecal samples.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）病毒RNA在粪便样本中的长期存在。
Lancet Gastroenterol Hepatol. 2020 May;5(5):434-435. doi: 10.1016/S2468-1253(20)30083-2. Epub 2020 Mar 20.
2
Clinical Features of 69 Cases With Coronavirus Disease 2019 in Wuhan, China.中国武汉 69 例 2019 年冠状病毒病患者的临床特征。
Clin Infect Dis. 2020 Jul 28;71(15):769-777. doi: 10.1093/cid/ciaa272.
3
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.《武汉 2019 年新型冠状病毒感染的肺炎 138 例住院患者临床特征分析》
JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585.
4
The Novel Coronavirus Originating in Wuhan, China: Challenges for Global Health Governance.源自中国武汉的新型冠状病毒：全球卫生治理面临的挑战
JAMA. 2020 Feb 25;323(8):709-710. doi: 10.1001/jama.2020.1097.
5
Drug-Resistant Bacteremia Transmitted by Fecal Microbiota Transplant.耐药菌血症通过粪便微生物群移植传播。
N Engl J Med. 2019 Nov 21;381(21):2043-2050. doi: 10.1056/NEJMoa1910437. Epub 2019 Oct 30.
6
Donor Screening for Fecal Microbiota Transplantation.粪便微生物群移植的供体筛选
N Engl J Med. 2019 Nov 21;381(21):2070-2072. doi: 10.1056/NEJMc1913670. Epub 2019 Oct 30.
7
International consensus conference on stool banking for faecal microbiota transplantation in clinical practice.国际共识会议关于粪便银行在临床实践中进行粪便微生物群移植。
Gut. 2019 Dec;68(12):2111-2121. doi: 10.1136/gutjnl-2019-319548. Epub 2019 Sep 28.
8
Diagnosis and Treatment of Clostridium difficile Infection.艰难梭菌感染的诊断与治疗
JAMA. 2018 Sep 11;320(10):1031-1032. doi: 10.1001/jama.2018.12194.
9
Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA).临床实践指南：成人和儿童艰难梭菌感染：美国传染病学会（IDSA）和美国医疗保健流行病学学会（SHEA） 2017 年更新。
Clin Infect Dis. 2018 Mar 19;66(7):e1-e48. doi: 10.1093/cid/cix1085.
10
Repeat Clostridium difficile Testing.重复艰难梭菌检测。
JAMA. 2016 Dec 13;316(22):2422-2423. doi: 10.1001/jama.2016.17173.